Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Glenmark concludes post marketing surveillance study on Favipiravir (FabiFlu®) in 1000+ COVID-19 patients

Posted On: 2021-09-15 05:23:01 (Time Zone: UTC)


Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. The PMS study commenced in July 2020 to evaluate the safety and efficacy of Favipiravir in mild to moderate COVID-19 patients. A total of 1083 patients were enrolled in the prospective, open label, multicentre, single arm study. Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects such as weakness, gastritis, diarrhoea, vomiting etc., were found to be mild in nature. The time for fever resolution was 4 days, while time for clinical cure was 7 days.

Glenmark's PMS study is the first and largest post marketing study conducted in India on Favipiravir in mild to moderate COVID-19 patients. Thirteen sites - both Government and private institutions - across Mumbai, Bangalore, Hyderabad, Nashik, Nagpur, and Trivandrum took part. The study was conducted in patients in line with the approved indication of the drug.

Commenting on these findings, Mr. Alok Malik, Group Vice President & Head, India Formulations, said, "This study was crucial as it examined the safety and efficacy of FabiFlu® in real-world settings, where multiple variables can impact the results. Despite these factors, the PMS study demonstrated FabiFlu®'s consistent ability to provide symptomatic relief and improve clinical outcomes in patients with mild to moderate COVID19. It is a step forward both for Glenmark and the medical community, as it reinforces the oral antiviral's multiple benefits in tackling the pandemic."

On June 19, 2020, Glenmark became the first company in India to receive restricted emergency use approval from India's drug regulator for Favipiravir (FabiFlu®), making it the first oral Favipiravir-approved medication in India for the treatment of mild to moderate COVID-19. The approval was granted as part of accelerated approval process, considering the emergency situation of the COVID-19 outbreak in India.

This PMS study continued to evaluate the safety and efficacy of Favipiravir (FabiFlu®) post its launch in the market. The average age of patients in the study was 40 years, with women comprising 40%, while men 60% of the study population. Hypertension (11%) and diabetes (8%) were the two most common comorbidities noted in these patients. Fever was present in all patients at baseline, followed by cough (81%), fatigue (46.2%), and new loss of taste (41%).

Shares of Glenmark Pharmaceuticals ltd was last trading in BSE at Rs. 531.55 as compared to the previous close of Rs. 518.95. The total number of shares traded during the day was 100884 in over 3800 trades.

The stock hit an intraday high of Rs. 533.45 and intraday low of 520. The net turnover during the day was Rs. 53079057.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Cyient Joins TM Forum to collaborate with global CSPs to drive digital transformation in the Communications industry

BLS International selected as National Business Correspondent for India's largest bank, State Bank of India

Clean Science and Technology Ltd to acquire immovable property for Rs. 32.01 crores

Godrej Industries Ltd to issue NCDs for Rs. 750 crore

HDFC announces festive home loan offer with rates at 6.70%

Fineotex Products now ECO PASSPORT certified by OEKO-TEX®, audit conducted by Hohenstein, Germany

L&T Hydrocarbon Engineering bags significant orders from GAIL, Air Products Middle East Industrial Gases LLC

Hon'ble High Court of Delhi passes an order in favour of EaseMyTrip regarding unsolicited messages

Sterling and Wilson Solar Limited commissions 66 MWp solar energy project in Jordan

RattanIndia Enterprises appoints Mr. Peeyush Kumar as Head for their Drone business

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%

PDS Multinational Fashions Limited appoints Raamann Ahuja as Group Chief Human Resources Officer

Mr. Sumit Kumar Shaw resigns from Websol Energy System Ltd

K P Energy Ltd receives LOI aggregating Rs. 119.73 crores

Gensol Engineering Ltd acquires 51.68% stake in Solarig Gensol Utilities Pvt Ltd

Action Construction Equipment Ltd fixes floor price for QIP as Rs. 254.55

HCL Technologies to Drive Digital Speed, Transformation for MKS Instruments

Choice International Ltd secures IRDAI nod for stake acquisition

SoftSol India Limited to consider loan of $5 mn to subsidiary

Firstsource awarded IIP 'We invest in people' Gold accreditation for the second time in a row

TCS' Quartz™ Named a Leading Crypto Player in Transaction Banking and Payments by Celent

Ind-Ra revises outlook on IVP Limited

Apollo Tricoat Tubes Ltd board allots 3,04,00,000 bonus equity shares

Indian Sucrose Ltd board approves expansion projects

R & B Denims Limited to participate in Cairo Fashion & Tex Fair, 2021

Zydus Healthcare Limited to sell two brands Mifegest and Cytolog

Websol Energy System Ltd announces resignation of CFO - Mr. Sumit Kumar Shaw

Anupam Finserv Ltd fixes Oct 7, 2021 as record date for stock split

Universal Autofoundry Ltd Board to consider Bonus Issue

APL Apollo Tubes Limited allots 12,48,96,000 bonus equity shares

Union Qualtiy Plastics Ltd announces resignation of Mr. Sandeep Kumar Patnaikuni

Wardwizard Innovations and Mobility Ltd approves rights issue of Rs. 49 crores

Ishan Dyes and Chemicals Ltd board approves allotment of 50 lakh warrants

RPP Infra Projects wins new orders worth INR 157.67 Crores

DJ Media Print & Logistics Limited has been empaneled by LIC of India, Divisional Office, Jabalpur

Big Bloc Construction partners with SCG International Corporation Co. Ltd

Tata Power receives 'Letter of Intent' from MAHAGENCO to supply 250 MW power in Maharashtra

Quess Corp's General Staffing division first in India to cross 250,000 associates

Alkem Laboratories Limited to close operations at Beta Block in Baddi facility

Tata Communications offers pay-as-you-go feature on Ethernet network services in India

VST launches 95 DI Ignito - India's first 9 HP Electric start Power Tiller & widest range of Brush Cutters

Equitas Small Finance Bank successfully facilitates over one million vaccinations in collaboration with the state governments of India

L&T Hydrocarbon Engineering wins significant order from Petronet LNG

Adani Green Energy Limited appoints Mr. Romesh Sobti as additional director

Kotak Mahindra Bank Ltd to invest in KFin Technologies Pvt Ltd

Welspun Corp Limited receives multiple orders aggregating to approx. Rs. 1400 crore

Delta Corp Limited to reopen casinos from Sep 20, 2021

Lupin Ltd gets 7 observations from USFDA for Goa facility

DCM Nouvelle Ltd performs Bhoomi Poojan for new plant at Hisar, Haryana

The Sukhjit Starch and Chemicals Ltd board approves warrants issue at Rs. 300


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020